1. Frequently Asked Clinical Questions
What is the primary clinical difference between IV infiltration and extravasation?
Infiltration refers to the inadvertent leakage of non-vesicant solutions into surrounding subcutaneous tissue, generally causing swelling, pallor, and cool skin without necrosis. Extravasation refers to the inadvertent leakage of vesicant medications (such as anthracycline chemotherapy, vinca alkaloids, or concentrated vasopressors) capable of causing severe cellular damage, tissue necrosis, blistering, and full-thickness ulceration requiring specific antidotes.
What are the core components of the CDC CLABSI prevention bundle?
The CDC CLABSI prevention bundle encompasses five primary evidence-based interventions: 1) Strict hand hygiene before line manipulation; 2) Maximal sterile barrier precautions during catheter insertion; 3) Chlorhexidine skin antisepsis (>0.5% chlorhexidine with 70% alcohol); 4) Optimal catheter site selection (avoiding femoral vein in adult patients); and 5) Daily assessment of catheter necessity with prompt removal of unnecessary lines.
How often should a PICC line dressing be changed?
In accordance with INS 2024 Standards, transparent semi-permeable membrane (TSM) dressings should be changed at least every 7 days, or immediately if the dressing becomes loose, damp, soiled, or non-occlusive. Gauze dressings placed under transparent dressings must be changed every 48 hours.
Why is a non-coring Huber needle required to access an implanted port like Celsite®?
Implanted vascular access ports feature a self-sealing silicone septum designed to endure hundreds to thousands of punctures. Standard beveled hypodermic needles slice a tiny core of silicone out of the septum, destroying its seal and shedding silicone particulate matter into the bloodstream. A non-coring (Huber) needle has a deflected point that slices between silicone fibers without coring, preserving the integrity and longevity of the port septum.
What should a patient do if their home infusion pump sounds an occlusion alarm?
First, pause the alarm. Check the infusion tubing systematically from the pump to the vascular access site: ensure all clamps (slide clamps, pinch clamps) are open, look for kinks or bent tubing, verify the patient's arm or body position is not pinching the line, and confirm the catheter dressing is intact. Never force-flush an occluded line. If the occlusion does not resolve immediately, contact your on-call home infusion nursing agency.
What is the catheter-to-vein ratio standard under the INS 2024 Standards of Practice?
The INS 2024 Standards dictate that the external diameter of a vascular access catheter should occupy no more than 45% of the internal vein lumen diameter, evaluated under real-time ultrasound. Adherence to this ratio preserves adequate venous blood flow around the cannula and reduces deep vein thrombosis (DVT) by up to 70%.
How is a Fishbane reaction distinguished from true anaphylaxis during IV iron infusions?
A Fishbane reaction is a transient, self-limiting complement activation triggered by labile iron nanoparticles, characterized by facial flushing, acute backache, or chest tightness without hypotension, wheezing, or stridor. Temporarily pausing the infusion for 15 minutes resolves symptoms in over 90% of patients without medication. In contrast, true IgE-mediated anaphylaxis presents with systemic hypotension, bronchospasm, and angioedema, requiring immediate permanent termination and IM epinephrine.
What Beyond-Use-Dating (BUD) applies to USP <797> Category 1 compounded sterile preparations?
Under the 2023 revision of USP Chapter <797>, Category 1 Compounded Sterile Preparations (CSPs) compounded in an unclassified Segregated Compounding Area (SCA) have an assigned Beyond-Use-Date of <=12 hours at controlled room temperature, or <=24 hours when stored in a refrigerator (2–8°C).